Related Experiment Video
Updated: Feb 7, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
Jordan E Axelrad1,2, Benjamin Lebwohl2, Edward Cuaresma2
11Division of Gastroenterology, Department of Medicine, Inflammatory Bowel Disease Center, NYU Langone Health, 240 East 38th Street, 23rd Floor, New York, NY USA.
Vancomycin-resistant Enterococcus (VRE) colonization in ICU patients was linked to a lower risk of acquiring other enteric infections. This suggests VRE may offer some protection against common gut pathogens.
Area of Science:
- Infectious Diseases
- Microbiology
- Critical Care Medicine
Background:
- Gut colonization with vancomycin-resistant Enterococcus (VRE) is a known risk factor for adverse patient outcomes.
- Understanding the impact of VRE colonization on the acquisition of other enteric pathogens is crucial for infection control.
Purpose of the Study:
- To evaluate the effect of VRE colonization on the subsequent risk of acquiring common enteric pathogens in intensive care unit (ICU) patients.
- To investigate the relationship between VRE colonization and the incidence of gastrointestinal infections.
Main Methods:
- A retrospective cohort study was conducted on adult ICU patients from 2012 to 2017.
- Patients were screened for VRE colonization and underwent stool testing using a gastrointestinal pathogen PCR panel, with or without Clostridium difficile testing.
- Cox proportional hazards modeling was employed to adjust for confounding factors.
Main Results:
- VRE colonization was identified in 17% of patients.
- Patients with VRE colonization showed a significantly lower likelihood of testing positive for other enteric pathogens (9.2% vs. 18%, p=0.01), including E. coli and viral infections.
- While not statistically significant, there was a trend towards increased C. difficile infections in VRE-colonized patients (15% vs. 10%, p=0.11).
- Multivariable analysis confirmed a decreased risk of positive GI PCR in VRE-colonized patients (aHR 0.47, p=0.02), persisting over 5 years.
Conclusions:
- VRE colonization is associated with a reduced risk of subsequent non-Clostridium difficile enteric infections.
- The findings suggest that VRE may exert a protective effect against the acquisition of common enteric pathogens, potentially through gut microbiome dominance.
Related Concept Videos
Physiology of Enteric Nervous System and Gut Health
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The Colonization of Land
Relative Risk
Drug Delivery: Enteral Route
Resistivity

